Skip to content
Biodatica
Start free

National Healthcare Group, Singapore

Singapore, Singapore

Grant-only
Sign in to watch

What changed

Study registered, no phase assigned: A Neuro-Technological Intervention for Adolescents With GAD

May 2025Trial registeredMay 22, 2025Source filing (opens the source filing in a new tab)

Momentum

45no change

Momentum 45 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R35 · $388k · non-dilutive

    Jun 1, 2024

    TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GUAN, LAN · NIGMS · award ends Mar 31, 2029 · An integrated approach to understanding the molecular mechanisms of cation-coupled transport

    NIH RePORTER · NIH RePORTER 11097386 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Dec 8, 2020

    Generalised Anxiety Disorder · RECRUITING · sponsor: National Healthcare Group, Singapore · A Neuro-Technological Intervention for Adolescents With GAD

    ClinicalTrials.gov · NCT03813290 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources